The global cervical dysplasia market was valued at USD 710.11 million in 2024 and is expected to grow at a CAGR of 7.6% during the forecast period. The global cervical dysplasia market is experiencing significant growth, driven by rising awareness about women’s health, increasing prevalence of human papillomavirus (HPV) infections, and advancements in diagnostic and treatment...